Sahpra warns against counterfeit GLP-1 products like Ozempic, citing health risks. Only registered products should be used; ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
which is one of the registered products containing GLP-1 agonists from Novo Nordisk. According to the watchdog, Ozempic in ...
Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk ... or 15 mg, or Ozempic at a dose of 1 mg.
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...
the chief executive of Ozempic maker Novo Nordisk warned Wednesday. “Honestly, I’m quite alarmed by what we see in the US now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN.
Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday.Sales of the company’s current blockbuster weight loss drug, Wegovy ...